858 Therapeutics
Operator of a biotechnology company intended to discover innovative therapeutics for the treatment of cancers that are resistant to current therapies. The company's platform offers to assess the impac...
Valuation
$140M
Latest known
Share Price
N/A
Total Raised
$110M
Last Round
N/A